These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 17924536)

  • 1. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
    Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA.
    Zhang ML; Lorson CL; Androphy EJ; Zhou J
    Gene Ther; 2001 Oct; 8(20):1532-8. PubMed ID: 11704813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
    Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH
    Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.
    Hofmann Y; Wirth B
    Hum Mol Genet; 2002 Aug; 11(17):2037-49. PubMed ID: 12165565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
    Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
    Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs.
    Madocsai C; Lim SR; Geib T; Lam BJ; Hertel KJ
    Mol Ther; 2005 Dec; 12(6):1013-22. PubMed ID: 16226920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing.
    Coady TH; Shababi M; Tullis GE; Lorson CL
    Mol Ther; 2007 Aug; 15(8):1471-8. PubMed ID: 17551501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.
    Riessland M; Brichta L; Hahnen E; Wirth B
    Hum Genet; 2006 Aug; 120(1):101-10. PubMed ID: 16724231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron.
    Singh NK; Singh NN; Androphy EJ; Singh RN
    Mol Cell Biol; 2006 Feb; 26(4):1333-46. PubMed ID: 16449646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Inhibitors of SLC9A-Type Sodium-Proton Exchangers on
    Kanda S; Moulton E; Butchbach MER
    Mol Pharmacol; 2022 Aug; 102(2):92-105. PubMed ID: 35667685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Securinine enhances SMN2 exon 7 inclusion in spinal muscular atrophy cells.
    Chen YC; Chang JG; Liu TY; Jong YJ; Cheng WL; Yuo CY
    Biomed Pharmacother; 2017 Apr; 88():708-714. PubMed ID: 28152480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2).
    Hofmann Y; Lorson CL; Stamm S; Androphy EJ; Wirth B
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9618-23. PubMed ID: 10931943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
    Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL
    Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients.
    Andreassi C; Jarecki J; Zhou J; Coovert DD; Monani UR; Chen X; Whitney M; Pollok B; Zhang M; Androphy E; Burghes AH
    Hum Mol Genet; 2001 Nov; 10(24):2841-9. PubMed ID: 11734549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.
    Cartegni L; Hastings ML; Calarco JA; de Stanchina E; Krainer AR
    Am J Hum Genet; 2006 Jan; 78(1):63-77. PubMed ID: 16385450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMN transcript stability: could modulation of messenger RNA degradation provide a novel therapy for spinal muscular atrophy?
    Heier CR; Gogliotti RG; DiDonato CJ
    J Child Neurol; 2007 Aug; 22(8):1013-8. PubMed ID: 17761657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
    Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C
    J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular pH change modulates the exon 7 splicing in SMN2 mRNA.
    Chen YC; Yuo CY; Yang WK; Jong YJ; Lin HH; Chang YS; Chang JG
    Mol Cell Neurosci; 2008 Oct; 39(2):268-72. PubMed ID: 18672065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.
    Mattis VB; Rai R; Wang J; Chang CW; Coady T; Lorson CL
    Hum Genet; 2006 Nov; 120(4):589-601. PubMed ID: 16951947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
    Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
    Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.